50% off Premium Yearly

NYSE:GL
This summary was created by AI, based on 5 opinions in the last 12 months.
Globe Life Inc. (GL-N) is recognized as a stable insurance provider, primarily noted for its consistent earnings growth and prudent use of cash reserves. Analysts highlight the stock's attractive valuation at 10x earnings and its solid return on equity (ROE) ranging from 20% to 22%. The company is strategically buying back shares while managing debt effectively. Current recommendations suggest a price target range between $147 and $172, indicating upside potential of up to 23% based on analysts' assessments. The stock also offers a modest yield of around 0.7% to 0.8%, aligning with long-term investment strategies favored by seasoned investors like Warren Buffet.
Globe Life Inc. is a American stock, trading under the symbol GL (previously GL-N on Stockchase) on the New York Stock Exchange (GL). It is usually referred to as NYSE:GL or GL
In the last year, 6 stock analysts published opinions about GL (previously GL-N on Stockchase). 6 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is TOP PICK. Read the latest stock experts' ratings for Globe Life Inc..
Globe Life Inc. was recommended as a Top Pick by The Panic-Proof Portfolio (Stockchase Research) on 2025-07-15. Read the latest stock experts ratings for Globe Life Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year 6 stock analysts on Stockchase covered Globe Life Inc.. The stock is worth watching.
On 2026-06-11, Globe Life Inc. (GL) stock closed at a price of $165.01.
We again reiterate GL, a Texas based personal insurance and medicare supplemental provider as a TOP PICK. It's a steady performer that trades at 11x earnings, 2x book and supports a 21% ROE. The company is prudently using some cash reserves to aggressively buy back shares and retire debt. We recommend trailing up the stop (from $136) to $150, looking to achieve $195 -- upside potential of 18%. Yield 0.7%
(Analysts’ price target is $175.72)